IG Has Overly “Negative” View Of Sales Incentives, Pfizer Counsel Says
Executive Summary
The HHS Inspector General's draft compliance guidance for the pharmaceutical industry takes an overly "negative" stance on compensation for sales representatives, Pfizer Corporate Compliance Counsel Doug Lankler said
You may also be interested in...
PhRMA Marketing Code Is Shifting Promotional Budgets To CME
Forest expects to devote more resources to continuing medical education teleconferences as industry and the prescribing community come into compliance with new guidelines on promotional practices
Pfizer To Audit Managed Care Grants Under Lipitor “Best Price” Settlement
Pfizer will fund an independent review of its managed care expenditures and best price calculation practices as part of a settlement of a Department of Justice investigation into Lipitor price reporting
PhRMA Marketing Code Is Shifting Promotional Budgets To CME
Forest expects to devote more resources to continuing medical education teleconferences as industry and the prescribing community come into compliance with new guidelines on promotional practices